<DOC>
	<DOCNO>NCT00197379</DOCNO>
	<brief_summary>The purpose study exploit new drug androgenetic alopecia still effective safe topical drug androgenetic alopecia . Roxithomycin one macrolide antibiotic immunomodulatory effect . We firstly find roxithromycin increase rate murine human hair follicle elongation vitro . Therefore , apply drug disease therapy .</brief_summary>
	<brief_title>The Effect 0.5 % Roxithromycin Lotion Androgenetic Alopecia</brief_title>
	<detailed_description>The topical therapy androgenetic alopecia still enough improve cosmetically . Thereforem try find new effective safe topical therapy disease . Roxithromycin antibacterial action also immunomodulatory anti-inflamatory potency . For example , roxitromycin inhibits T cell responces mitogens production cytokine , IL-2 IL-5 . We firstly find roxitromycin increase human murine hair elongation vitro inhibit apoptosis hair bulb . Then , wish apply roxithromycin therapy androgenetic alopecia .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Roxithromycin</mesh_term>
	<criteria>Androgenetic alopecia Cicatricial alopecia Allergy roxitromycin Children ( 19years old young ) Pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>androgenetic alopecia</keyword>
	<keyword>roxitromycin</keyword>
	<keyword>apoptosis</keyword>
</DOC>